Clinical trial
A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
NCT00720174 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of Doxorubicin and A12 in Advanced Soft Tissue Sarcoma
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- Not reported
- Enrollment
- 30 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
adult angiosarcoma, adult desmoplastic small round cell tumor, adult epithelioid sarcoma, adult extraskeletal myxoid chondrosarcoma, adult extraskeletal osteosarcoma, adult fibrosarcoma, adult leiomyosarcoma, adult liposarcoma, adult malignant mesenchymoma, adult malignant peripheral nerve sheath tumor, adult rhabdomyosarcoma, adult synovial sarcoma, adult undifferentiated high grade pleomorphic sarcoma of bone, childhood angiosarcoma, childhood desmoplastic small round cell tumor, childhood epithelioid sarcoma, childhood fibrosarcoma, childhood leiomyosarcoma, childhood liposarcoma, childhood malignant mesenchymoma, childhood malignant peripheral nerve sheath tumor, childhood pleomorphic rhabdomyosarcoma, childhood rhabdomyosarcoma with mixed embryonal and alveolar features, childhood synovial sarcoma, dermatofibrosarcoma protuberans, malignant adult hemangiopericytoma, malignant childhood hemangiopericytoma, metastatic childhood soft tissue sarcoma, previously treated childhood rhabdomyosarcoma, recurrent adult soft tissue sarcoma, recurrent childhood rhabdomyosarcoma, recurrent childhood soft tissue sarcoma, stage iii adult soft tissue sarcoma, stage iv adult soft tissue sarcoma, untreated childhood rhabdomyosarcoma